Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unlock the Cell: Intracellular Inflammatory Pathways and Flow Cytometry Study for Castleman's Disease

NCT02853968 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02853968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unlock the Cell: Intracellular Inflammatory Pathways and Flow Cytometry Study for Castleman's Disease
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Completed
Start date
February 29, 2016
Completion date
March 30, 2019
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiofollicular lymph hyperplasia, angiofollicular lymphoid hyperplasia, castleman disease, castleman's disease, giant lymph node hyperplasia, glnh, hyperplasia